We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Neutrons Show Promise in Treating Some Sarcomas, Adenocarcinomas, Locally Advanced Prostate Cancers; Research Continues

Timothy F. Kirn
JAMA. 1987;258(13):1700-1701. doi:10.1001/jama.1987.03400130014004.
Text Size: A A A
Published online


IN A 1969 address to the American Society of Therapeutic Radiologists, Mary Catterall, MD, a British radiologist, predicted that ultimately all radiotherapists would be using neutrons to treat some patients. But since that early enthusiasm, there has been a steady "decrescendo" of interest, to quote one radiologist.

Decrescendo is not disappointment, however, say neutron researchers. Rather, while it appears that neutron treatments are not a better form of radiotherapy overall, they may have specific applications. Recent results indicate that neutron radiotherapy is an effective treatment for bone and soft tissue sarcomas, for adenocarcinomas— in particular, salivary gland tumors— and for locally advanced prostate cancers.

Robert Stone, MD, is believed to be the first physician to attempt treating patients with neutrons—in 1939 at the E. O. Lawrence Cyclotron in Berkeley, Calif, barely seven years after the British physicist Sir John Chadwick first identified the particle. But Stone's results were poor, his


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.